首页> 外文学位 >Development of Injectable, Stimuli-Responsive Biomaterials as Active Scaffolds for Applications in Advanced Drug Delivery and Osteochondral Tissue Regeneration.
【24h】

Development of Injectable, Stimuli-Responsive Biomaterials as Active Scaffolds for Applications in Advanced Drug Delivery and Osteochondral Tissue Regeneration.

机译:可注射的,对刺激有反应的生物材料作为活性支架的开发,用于先进的药物递送和软骨组织再生。

获取原文
获取原文并翻译 | 示例

摘要

Osteoarthritis (OA) is a degenerative joint disease that occurs when the cartilage matrix begins to breakdown. Every year, over 3.1 million surgeries are performed in an effort to treat damaged cartilage tissue. Current treatment options such as osteochondral tissue grafting, micro-fracturing, and total knee replacements (TKRs) are effective in alleviating symptoms associated with OA, but often fail to promote the regeneration of normal cartilage. Therefore, due to the limitations of the current treatment options available, it has become necessary to develop better medical solutions to restore or regenerate cartilage tissue previously damaged by OA.;Stimuli-responsive hydrogels, capable of exhibiting dramatic changes in swelling behavior, network structure, permeability and mechanical strength in response to changes in their local environment, have emerged as potential candidates as active scaffolds for several tissue engineering applications. Magneto-responsive biomaterials have become a subject of interest in the field of tissue engineering as their physical and structural properties could be manipulated spatiotemporally by varying the magnetic field strength, making them useful for applications in advanced drug delivery and osteochondral tissue regeneration. Thus, the goal of this thesis was to investigate the feasibility of developing an injectable, magneto-responsive hydrogel scaffold capable of delivering viable stem cell populations to a cartilage defect, and to spatiotemporally control the regeneration of the cartilage tissue in vivo..;A magneto-responsive biomaterial was made by adding functional paramagnetic iron (III) oxide Fe3O4 nanoparticles into a thermosensitive pNiPAAm-based hydrogel with degradable PAMAM-based crosslinking macromers. From our tangential force measurements, we were able to determine that, under a low magnetic field of 0.3 tesla, physiologically-relevant engineering stresses of 52.5 Pa and 29.6 Pa were generated for hydrogels with 625 mug/mL of 50 or 500 nm nanoparticles (NPs), respectively. Furthermore, primary Mesenchymal Stem Cells (MSCs) were encapsulated within the nanocomposite hydrogel up to seven days, showing that the inclusion of the nanoparticles had no significant impact on MSC viability. These results show that these magnetic hydrogels could be used as injectable scaffolds that permit real-time spatiotemporal control of deformation of the hydrogel, leading to the physical stimulation of encapsulated cells.;Next, to increase macro-porosity within the scaffold, degradable gelatin micro-particles were added to the magnetic hydrogel formulation. Addition of the micro-particles had no adverse effect on cellularity, gelation kinetics or hydrogel formation. However, the micro-particles did have a diminishing effect on the magnetic saturation of our magneto-responsive hydrogels. Furthermore, the feasibility of using magnetic field to accelerate the release of a therapeutic agent from the GMP-composite magnetic hydrogels was investigated.;Finally, the effects of short term magnetic stimulation on stem cell differentiation were also explored. Results showed that magnetic stimulation increases cellularity and hydrogel calcification increased with increases in NP loading but decreased with increases in magnetic stimulation. Furthermore, Alkaline Phosphatase (ALP) expression increased with NP loading, but decreased with magnetic stimulation. It is our hope is that the results presented in this thesis would encourage other scientists to explore using novel stimuli-responsive biomaterials to restore severely damaged tissues.
机译:骨关节炎(OA)是一种退化性关节疾病,在软骨基质开始分解时会发生。每年,要进行超过310万例外科手术以治疗受损的软骨组织。当前的治疗选择,例如骨软骨组织移植,微骨折和全膝关节置换(TKR),可有效缓解与OA相关的症状,但通常无法促进正常软骨的再生。因此,由于当前可用治疗方法的局限性,有必要开发更好的医学解决方案来恢复或再生先前被OA破坏的软骨组织。刺激响应水凝胶,能够在肿胀行为,网络结构方面展现出巨大的变化响应于其局部环境的变化的渗透性和机械强度已经作为潜在的候选物而成为用于多种组织工程应用的活性支架。磁响应生物材料已经成为组织工程领域的关注主题,因为它们的物理和结构特性可以通过改变磁场强度在时空上进行调节,从而使其可用于高级药物输送和软骨组织再生。因此,本发明的目的是研究开发可注射的,磁响应的水凝胶支架的可行性,该支架能够将活的干细胞群体递送至软骨缺损,并在时空上控制体内软骨组织的再生。磁响应生物材料是通过将功能性顺磁性氧化铁(III)Fe3O4纳米颗粒添加到具有可降解PAMAM基交联大分子单体的热敏pNiPAAm基水凝胶中制成的。通过切向力测量,我们能够确定,在0.3特斯拉的低磁场下,对于625杯/ mL的50或500 nm纳米颗粒(NPs),水凝胶产生了与生理相关的52.5 Pa和29.6 Pa的工程应力。 ), 分别。此外,原代间充质干细胞(MSCs)被封装在纳米复合水凝胶中长达7天,这表明纳米粒子的包含对MSC的生存能力没有重大影响。这些结果表明,这些磁性水凝胶可用作可注射的支架,可实时控制水凝胶的变形,从而对封装的细胞进行物理刺激;接着,增加支架内的大孔,可降解明胶微粉-将颗粒加入磁性水凝胶制剂中。微粒的添加对细胞性,胶凝动力学或水凝胶形成没有不利影响。但是,微粒确实对我们的磁响应水凝胶的磁饱和度有减小的影响。此外,还研究了利用磁场促进从GMP复合磁性水凝胶中释放治疗剂的可行性。最后,还探讨了短期磁刺激对干细胞分化的影响。结果表明,磁刺激增加细胞数量,水凝胶钙化随NP负荷增加而增加,但随磁刺激增加而减少。此外,碱性磷酸酶(ALP)的表达随NP的加载而增加,但随磁刺激而降低。我们希望,本文提出的结果将鼓励其他科学家探索使用新颖的刺激反应性生物材料来恢复严重受损的组织。

著录项

  • 作者

    Adedoyin, Adedokun Adediji.;

  • 作者单位

    Northeastern University.;

  • 授予单位 Northeastern University.;
  • 学科 Chemical engineering.;Bioengineering.
  • 学位 Ph.D.
  • 年度 2018
  • 页码 128 p.
  • 总页数 128
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号